Association Between Pre-Treatment and Post-Treatment 3-Month Red Cell Distribution Width with Three-Year Prognosis of Prostate Cancer

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Liu X, Yu C, Bi Y, Zhang ZJ. Trends and age-period-cohort effect on incidence and mortality of prostate cancer from 1990 to 2017 in China. Public Health. 2019;172:70–80. doi:10.1016/j.puhe.2019.04.016
   PubMed Web of Science ®Google Scholar
• Wilkins LJ, Tosoian JJ, Sundi D, et al. Surgical management of high-risk, localized prostate cancer. Nat Rev Urol. 2020;17:679–690. doi:10.1038/s41585-020-00384-7
   PubMed Web of Science ®Google Scholar
• Taylor JM, Chen VE, Miller RC, Greenberger BA. The impact of prostate cancer treatment on quality of life: a narrative review with a focus on randomized data. Res Rep Urol. 2020;12:533–546. doi:10.2147/RRU.S243088
   PubMed Web of Science ®Google Scholar
• Hassanipour S, Delam H, Arab-Zozani M, et al. Survival rate of prostate cancer in asian countries: a systematic review and meta-analysis. Ann Glob Health. 2020;86:2. doi:10.5334/aogh.2607
   PubMed Web of Science ®Google Scholar
• Attard G, Parker C, Eeles RA, et al. Prostate cancer. Lancet. 2016;387:70–82. doi:10.1016/S0140-6736(14)61947-4
   PubMed Web of Science ®Google Scholar
• Cuzick J, Thorat MA, Andriole G, et al. Prevention and early detection of prostate cancer. Lancet Oncol. 2014;15:e484–492. doi:10.1016/S1470-2045(14)70211-6
   PubMed Web of Science ®Google Scholar
• Goldstein E, Yeghiazaryan K, Ahmad A, Giordano FA, Fröhlich H, Golubnitschaja O. Optimal multiparametric set-up modelled for best survival outcomes in palliative treatment of liver malignancies: unsupervised machine learning and 3 PM recommendations. EPMA J. 2020;11:505–515. doi:10.1007/s13167-020-00221-2
   PubMed Web of Science ®Google Scholar
• Montagnana M, Danese E. Red cell distribution width and cancer. Ann Transl Med. 2016;4:399. doi:10.21037/atm.2016.10.50
   PubMed Web of Science ®Google Scholar
• Celik A, Aydin N, Ozcirpici B, et al. Elevated red blood cell distribution width and inflammation in printing workers. Med Sci Monit. 2013;19:1001–1005. doi:10.12659/MSM.889694
   PubMed Web of Science ®Google Scholar
• Hsueh C-Y, Lau H-C, Li S, et al. Pretreatment level of red cell distribution width as a prognostic indicator for survival in a large cohort study of male laryngeal squamous carcinoma. Front Oncol. 2019;9:271. doi:10.3389/fonc.2019.00271
   PubMed Web of Science ®Google Scholar
• Karampitsakos T, Akinosoglou K, Papaioannou O, et al. Increased red cell distribution width is associated with disease severity in hospitalized adults with SARS-CoV-2 infection: an observational multicentric study. Front Med (Lausanne). 2020;7:616292. doi:10.3389/fmed.2020.616292
   PubMed Web of Science ®Google Scholar
• Borné Y, Smith JG, Melander O, Engström G. Red cell distribution width in relation to incidence of coronary events and case fatality rates: a population-based cohort study. Heart. 2014;100:1119–1124. doi:10.1136/heartjnl-2013-305028
   PubMed Web of Science ®Google Scholar
• Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M; for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117:163–168. doi:10.1161/CIRCULATIONAHA.107.727545
   PubMed Web of Science ®Google Scholar
• Pedrazzani C, Tripepi M, Turri G, et al. Prognostic value of red cell distribution width (RDW) in colorectal cancer. Results from a single-center cohort on 591 patients. Sci Rep. 2020;10:1072. doi:10.1038/s41598-020-57721-4
   PubMed Web of Science ®Google Scholar
• Yazici P, Demir U, Bozkurt E, Isil GR, Mihmanli M. The role of red cell distribution width in the prognosis of patients with gastric cancer. Cancer Biomark. 2017;18:19–25. doi:10.3233/CBM-160668
   PubMed Web of Science ®Google Scholar
• Ichinose J, Murakawa T, Kawashima M, et al. Prognostic significance of red cell distribution width in elderly patients undergoing resection for non-small cell lung cancer. J Thorac Dis. 2016;8:3658–3666. doi:10.21037/jtd.2016.12.44
   PubMed Web of Science ®Google Scholar
• Li Z, Hong N, Robertson M, Wang C, Jiang G. Preoperative red cell distribution width and neutrophil-to-lymphocyte ratio predict survival in patients with epithelial ovarian cancer. Sci Rep. 2017;7:43001. doi:10.1038/srep43001
   PubMed Web of Science ®Google Scholar
• Albayrak S, Zengin K, Tanik S, Bakirtas H, Imamoglu A, Gurdal M. Red cell distribution width as a predictor of prostate cancer progression. Asian Pac J Cancer Prev. 2014;15:7781–7784. doi:10.7314/APJCP.2014.15.18.7781
   PubMedGoogle Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. doi:10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Kucera R, Pecen L, Topolcan O, et al. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions. EPMA J. 2020;11:399–418. doi:10.1007/s13167-020-00214-1
   PubMed Web of Science ®Google Scholar
• Samec M, Liskova A, Koklesova L, et al. Flavonoids against the Warburg phenotype-concepts of predictive, preventive and personalised medicine to cut the Gordian knot of cancer cell metabolism. EPMA J. 2020;11:377–398. doi:10.1007/s13167-020-00217-y
   PubMed Web of Science ®Google Scholar
• Cho MC, Yoo S, Choo MS, Son H, Jeong H. Lymphocyte-to-monocyte ratio is a predictor of clinically significant prostate cancer at prostate biopsy. Prostate. 2021;81:1278–1286. doi:10.1002/pros.24222
   PubMed Web of Science ®Google Scholar
• Bauckneht M, Rebuzzi SE, Signori A, et al. The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study). Eur J Nucl Med Mol Imaging. 2021. doi:10.1007/s00259-021-05550-6
   Google Scholar
• Szkandera J, Stotz M, Absenger G, et al. Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014;110:183–188. doi:10.1038/bjc.2013.701
   PubMed Web of Science ®Google Scholar
• Aprile G, Basile D, Giaretta R, et al. The clinical value of nutritional care before and during active cancer treatment. Nutrients. 2021;13:1196. doi:10.3390/nu13041196
   PubMed Web of Science ®Google Scholar
• Koury MJ, Ponka P. New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu Rev Nutr. 2004;24:105–131. doi:10.1146/annurev.nutr.24.012003.132306
   PubMed Web of Science ®Google Scholar
• Spivak JL. The anaemia of cancer: death by a thousand cuts. Nat Rev Cancer. 2005;5:543–555. doi:10.1038/nrc1648
   PubMed Web of Science ®Google Scholar
• Price AJ, Travis RC, Appleby PN, et al. Circulating folate and vitamin B12 and risk of prostate cancer: a collaborative analysis of individual participant data from six cohorts including 6875 cases and 8104 controls. Eur Urol. 2016;70:941–951. doi:10.1016/j.eururo.2016.03.029
   PubMed Web of Science ®Google Scholar
• McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90:215–219. doi:10.1002/bjs.4038
   PubMed Web of Science ®Google Scholar
• Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–867. doi:10.1038/nature01322
   PubMed Web of Science ®Google Scholar
• Kamel MG, Istanbuly S, Abd-Elhay FA-E, et al. Examined and positive lymph node counts are associated with mortality in prostate cancer: a population-based analysis. Urol Int. 2020;104:699–709. doi:10.1159/000505410
   PubMed Web of Science ®Google Scholar
• Valero J, Peleteiro P, Henríquez I, et al. Age, Gleason Score, and PSA are important prognostic factors for survival in metastatic castration-resistant prostate cancer. Results of The Uroncor Group (Uro-Oncological Tumors) of the Spanish Society of Radiation Oncology (SEOR). Clin Transl Oncol. 2020;22:1378–1389. doi:10.1007/s12094-019-02274-w
   PubMed Web of Science ®Google Scholar
• Liang Z, Xie B, Li J, et al. Hypertension and risk of prostate cancer: a systematic review and meta-analysis. Sci Rep. 2016;6:31358. doi:10.1038/srep31358
   PubMed Web of Science ®Google Scholar
• Dickerman BA, Markt SC, Koskenvuo M, Pukkala E, Mucci LA, Kaprio J. Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins. Cancer Causes Control. 2016;27:1049–1058. doi:10.1007/s10552-016-0778-6
   PubMed Web of Science ®Google Scholar
• Zuccolo L, Lewis SJ, Donovan JL, Hamdy FC, Neal DE, Smith GD. Alcohol consumption and PSA-detected prostate cancer risk–a case-control nested in the ProtecT study. Int J Cancer. 2013;132:2176–2185. doi:10.1002/ijc.27877
   PubMed Web of Science ®Google Scholar